How have STX shares performed in 2024?

Shield Therapeutics' stock was trading at GBX 6.70 on January 1st, 2024. Since then, STX stock has decreased by 78.4% and is now trading at GBX 1.45. View the best growth stocks for 2024 here .

What other stocks do shareholders of Shield Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shield Therapeutics investors own include AcelRx Pharmaceuticals (ACRX) , Rockwell Medical (RMTI) , Cara Therapeutics (CARA) , Caladrius Biosciences (CLBS) , Cellectis (CLLS) , Geron (GERN) , Concepta PLC (CPT.L) (CPT) , Fresnillo (FRES) , OptiBiotix Health (OPTI) and SkinBioTherapeutics (SBTX) .

How do I buy shares of Shield Therapeutics?

Shares of STX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:STX

Shield Therapeutics (STX) Share Price, News & Analysis

→ The only accurate crypto trading system I know … (From Weiss Ratings) (Ad)

Free STX Stock Alerts

GBX 1.45

-0.03 (-1.69%)

(As of 03:39 PM ET)

Compare

Today's Range: 1.42
▼
1.50
50-Day Range: 1.45
▼
5.86
52-Week Range: 1.42
▼
12.85

Volume: 1.17 million shs
Average Volume: 5.25 million shs
Market Capitalization: £11.34 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Headlines

Get Shield Therapeutics alerts:

Ad Weiss Ratings

The only accurate crypto trading system I know …

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

Here's what our expert says you should buy before April 14.

About Shield Therapeutics Stock (LON:STX)

Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.

STX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

STX Stock News Headlines

April 10, 2024 | msn.com

Neutral Switzerland joins European Sky Shield defence project

April 1, 2024 | tmcnet.com

American Home Shield Offering 40% Off ShieldGold™ For Limited Time

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

March 29, 2024 | msn.com

A Real Life Invisibility Shield for Privacy in Public Places

March 11, 2024 | tmcnet.com

Seal Shield to Showcase Shyld AI, the World's First Intelligent, Autonomous, UV-C Disinfection System at HIMSS 2024

February 23, 2024 | lse.co.uk

LONDON MARKET CLOSE: FTSE 100 takes hit ahead of FOMC minutes

February 22, 2024 | morningstar.com

Shield Therapeutics PLC STX

February 13, 2024 | uk.finance.yahoo.com

Shield Therapeutics plc (STX.L)

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

January 24, 2024 | finance.yahoo.com

Shield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years ago

December 28, 2023 | finance.yahoo.com

Shield Therapeutics plc (LON:STX) Is Expected To Breakeven In The Near Future

October 20, 2023 | proactiveinvestors.com

Shield Therapeutics to present at NPWH conference this month

October 12, 2023 | marketwatch.com

Shield Therapeutics CFO Hans-Peter Rudolf to Step Down

October 12, 2023 | proactiveinvestors.com

Shield Therapeutics launches executive search process as CFO steps down

October 5, 2023 | finance.yahoo.com

Shield Therapeutics "couldn't be more pleased" with Viatris collaboration

October 5, 2023 | finance.yahoo.com

Shield Therapeutics' pricing will be "key metric" - Proactive Research Analyst

October 3, 2023 | proactiveinvestors.com

Shield Therapeutics secures debt facility, retail share offer closes soon

September 30, 2023 | finance.yahoo.com

Shield Therapeutics First Half 2023 Earnings: US$0.025 loss per share (vs US$0.069 loss in 1H 2022)

September 29, 2023 | msn.com

Shield Therapeutics hails progress in Stateside venture as losses narrow

September 28, 2023 | marketwatch.com

Shield Therapeutics Shares Fall After Discounted Equity Raise

September 5, 2023 | finance.yahoo.com

Private companies who hold 41% of Shield Therapeutics plc (LON:STX) gained 17%, institutions profited as well

July 29, 2023 | proactiveinvestors.com

Shield Therapeutics : First signs of hoped-for Accrufer Rx inflection

July 25, 2023 | finanznachrichten.de

Hardman & Co Research on Shield Therapeutics (STX): Accrufer Rx momentum gathering

July 25, 2023 | finance.yahoo.com

Shield Therapeutics "really starting to fire on all cylinders"

July 20, 2023 | marketwatch.com

Shield Therapeutics Shares Rise as US Prescriptions for Accrufer Soar

July 20, 2023 | msn.com

Shield Therapeutics makes waves in US as iron deficiency prescriptions ramp up

July 20, 2023 | proactiveinvestors.com

Shield Therapeutics reports 173% Accrufer prescription growth

See More Headlines

Receive STX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shield Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: LON:STX
CUSIP: N/A
CIK: N/A
Web: www.shieldtherapeutics.com
Phone: +44-191-5118500
Fax: N/A
Employees: 27
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.12)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 62.15
P/E Growth: N/A
Net Income: £-48,880,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -146.62%
Return on Assets: -42.79%

Debt

Debt-to-Equity Ratio: 21.30
Current Ratio: 2.95
Quick Ratio: 2.16

Sales & Book Value

Annual Sales: £7.40 million
Price / Sales: 1.53
Cash Flow: GBX 0.23 per share
Price / Cash Flow: 6.36
Book Value: GBX 4 per share
Price / Book: 0.36

Miscellaneous

Outstanding Shares: 782,060,000
Free Float: N/A
Market Cap: £11.34 million
Optionable: Not Optionable
Beta: 0.84

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Gregory P. Madison (Age 57)
CEO & Executive Director
Comp: $678k
Dr. Christian Schweiger M.D. (Age 58)
Ph.D., Co-Founder & Non Executive Director
Comp: $45k
Mr. Santosh Shanbhag (Age 46)
Chief Financial Officer
Ms. Lucy Kate Huntington-Bailey
General Counsel & Company Secretary
Ms. Suzanne Wood
Group HR Director
Ms. Carol Akinola
Head of Pharmacovigilance & Medical Information
Mr. Andrew Hurley (Age 55)
Chief Commercial Officer
Kate Armanetti
Senior Director of People & Culture

Key Competitors

View All Competitors

STX Stock Analysis - Frequently Asked Questions

How have STX shares performed in 2024?: Shield Therapeutics' stock was trading at GBX 6.70 on January 1st, 2024. Since then, STX stock has decreased by 78.4% and is now trading at GBX 1.45.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Shield Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Shield Therapeutics investors own include AcelRx Pharmaceuticals (ACRX), Rockwell Medical (RMTI), Cara Therapeutics (CARA), Caladrius Biosciences (CLBS), Cellectis (CLLS), Geron (GERN), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES), OptiBiotix Health (OPTI) and SkinBioTherapeutics (SBTX).
How do I buy shares of Shield Therapeutics?: Shares of STX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:STX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial